Literature DB >> 34003385

Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States.

Gregory Carter1,2,3, Beth Meyerson4,5,6, Patrick Rivers5, Richard Crosby7, Carrie Lawrence8, Summer Dawn Cope9, David DeBruicker10, Steven Levin9,11, Whitney Meeks10, Christopher Thomas9,11, Brooklyne Turner10, Chris Abert10,12, Haley Coles11, Alicia Allen11, Eduardo Gonzalez-Fagoaga13, Ravi Grivois-Shah14.   

Abstract

We explored knowledge, beliefs, and acceptability of pre-exposure prophylaxis (PrEP) for HIV prevention with reference to stigma among people who inject drugs (PWID) in two predominately rural U.S. states. We conducted interviews with 65 current or former PWID aged 18 years or older and living in Arizona or Indiana. Most (63%) of the interviewees were not aware of PrEP. They often confused PrEP with HIV treatment, and many believed that PrEP was only for sexual risk or gay sexual risk. Once they understood that PrEP was recommended for PWID, the participants held a positive view of PrEP and felt that a once-daily pill was feasible. Experiences of stigma about drug use remained a crucial barrier to accessing healthcare and PrEP. This was often linked with anticipated or expressed homophobia. PrEP interventions among PWID must focus on education and the confluence of stigmas in which PWID find themselves when considering PrEP.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  HIV prevention; Healthcare access; People who inject drugs; PrEP; Stigma

Mesh:

Substances:

Year:  2021        PMID: 34003385     DOI: 10.1007/s10461-021-03304-x

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  2 in total

1.  Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014.

Authors:  Jon E Zibbell; Alice K Asher; Rajiv C Patel; Ben Kupronis; Kashif Iqbal; John W Ward; Deborah Holtzman
Journal:  Am J Public Health       Date:  2017-12-21       Impact factor: 9.308

2.  Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012.

Authors:  Jon E Zibbell; Kashif Iqbal; Rajiv C Patel; Anil Suryaprasad; Kathy J Sanders; Loretta Moore-Moravian; Jamie Serrecchia; Steven Blankenship; John W Ward; Deborah Holtzman
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-05-08       Impact factor: 17.586

  2 in total
  4 in total

1.  An Experimental Study of the Effects of Patient Race, Sexual Orientation, and Injection Drug Use on Providers' PrEP-Related Clinical Judgments.

Authors:  Sarah K Calabrese; David A Kalwicz; Djordje Modrakovic; Valerie A Earnshaw; E Jennifer Edelman; Samuel R Bunting; Ana María Del Río-González; Manya Magnus; Kenneth H Mayer; Nathan B Hansen; Trace S Kershaw; Joshua G Rosenberger; Douglas S Krakower; John F Dovidio
Journal:  AIDS Behav       Date:  2021-11-09

2.  Awareness and Correlates of HIV Pre-Exposure Prophylaxis (PrEP) Among HIV-negative People Who Access Syringe Services in Seattle, Washington.

Authors:  Maria A Corcorran; John D Scott; Joe Tinsley; Anna Wald; Sara N Glick
Journal:  Subst Use Misuse       Date:  2021-12-13       Impact factor: 2.362

3.  Low Knowledge of HIV PrEP Within a Midwestern US Cohort of Persons who Inject Drugs.

Authors:  Sena Sayood; Laura R Marks; Rupa Patel; Nathanial S Nolan; Stephen Y Liang; Michael J Durkin
Journal:  Open Forum Infect Dis       Date:  2021-11-10       Impact factor: 3.835

4.  PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.

Authors:  Suzan M Walters; David Frank; Brent Van Ham; Jessica Jaiswal; Brandon Muncan; Valerie Earnshaw; John Schneider; Samuel R Friedman; Danielle C Ompad
Journal:  AIDS Behav       Date:  2021-10-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.